SG10201403702SA - Vaccines and compositions against streptococcus pneumoniae - Google Patents

Vaccines and compositions against streptococcus pneumoniae

Info

Publication number
SG10201403702SA
SG10201403702SA SG10201403702SA SG10201403702SA SG10201403702SA SG 10201403702S A SG10201403702S A SG 10201403702SA SG 10201403702S A SG10201403702S A SG 10201403702SA SG 10201403702S A SG10201403702S A SG 10201403702SA SG 10201403702S A SG10201403702S A SG 10201403702SA
Authority
SG
Singapore
Prior art keywords
vaccines
streptococcus pneumoniae
compositions against
against streptococcus
compositions
Prior art date
Application number
SG10201403702SA
Inventor
Todd Gierahn
Richard Malley
Original Assignee
Genocea Biosciences Inc
Childrens Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genocea Biosciences Inc, Childrens Medical Center filed Critical Genocea Biosciences Inc
Publication of SG10201403702SA publication Critical patent/SG10201403702SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG10201403702SA 2009-06-29 2010-06-29 Vaccines and compositions against streptococcus pneumoniae SG10201403702SA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US22154109P 2009-06-29 2009-06-29
US24059809P 2009-09-08 2009-09-08
US24061609P 2009-09-08 2009-09-08
US31626710P 2010-03-22 2010-03-22

Publications (1)

Publication Number Publication Date
SG10201403702SA true SG10201403702SA (en) 2014-09-26

Family

ID=43449681

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201403702SA SG10201403702SA (en) 2009-06-29 2010-06-29 Vaccines and compositions against streptococcus pneumoniae
SG2011096898A SG177402A1 (en) 2009-06-29 2010-06-29 Vaccines and compositions against streptococcus pneumoniae

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2011096898A SG177402A1 (en) 2009-06-29 2010-06-29 Vaccines and compositions against streptococcus pneumoniae

Country Status (15)

Country Link
US (2) US10105412B2 (en)
EP (1) EP2448592B1 (en)
JP (1) JP5931724B2 (en)
KR (1) KR101748453B1 (en)
CN (2) CN102548572A (en)
AU (1) AU2010273708B2 (en)
BR (1) BRPI1011919A2 (en)
CA (1) CA2803061A1 (en)
IL (1) IL217166A0 (en)
IN (1) IN2012DN00791A (en)
MX (1) MX2012000158A (en)
NZ (1) NZ597858A (en)
RU (1) RU2580299C2 (en)
SG (2) SG10201403702SA (en)
WO (1) WO2011008548A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008548A1 (en) 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
WO2011112906A2 (en) 2010-03-12 2011-09-15 Children's Medical Center Corporation Novel immunogens and methods for discovery and screening thereof
CA2822715C (en) * 2010-12-21 2019-04-30 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Determination of the efficacy of an anti-mycobacterial vaccination
WO2012100234A1 (en) 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
UY33939A (en) * 2011-03-09 2012-09-28 Glaxosmithkline Llc INHIBITORS OF THE PEPTIDE DESFORMILASA
ES2864764T3 (en) 2011-05-11 2021-10-14 Childrens Medical Center Immunogenic composition presenting multiple antigens, and its methods and uses
EP2804627B1 (en) * 2012-01-20 2019-08-14 Genocea Biosciences Inc. Fused antigen vaccines and compositions against streptococcus pneumoniae
WO2014018904A1 (en) * 2012-07-26 2014-01-30 Genocea Biosciences, Inc. Fused antigen vaccines and compositions against streptococcus pneumoniae
ES2959258T3 (en) 2013-02-07 2024-02-22 Childrens Medical Center Protein antigens that provide protection against pneumococcal colonization and/or disease
US20150079132A1 (en) * 2013-09-17 2015-03-19 Path Evoking protection against streptotoccus pneumoniae incorporating b-cell and t-cell pneumococcal protein antigens and pneumococcal polysaccharides delivered concomitantly
EP3131579A4 (en) * 2014-04-18 2017-10-25 The Children's Medical Center Corporation Vaccine adjuvant compositions
US9815886B2 (en) 2014-10-28 2017-11-14 Adma Biologics, Inc. Compositions and methods for the treatment of immunodeficiency
HRP20220573T1 (en) * 2017-01-20 2022-06-10 Pfizer Inc. Immunogenic compositions for use in pneumococcal vaccines
US10259865B2 (en) 2017-03-15 2019-04-16 Adma Biologics, Inc. Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection
CN110730670A (en) 2017-03-28 2020-01-24 儿童医疗中心有限公司 Multi-antigen presentation system (MAPS) -based staphylococcus aureus vaccines, immunogenic compositions, and uses thereof
ES2967001T3 (en) 2017-06-23 2024-04-25 Affinivax Inc Immunogenic compositions
BR112021004193A2 (en) 2018-09-12 2021-05-25 Affinivax, Inc. multivalent pneumococcal vaccines
RU2728938C1 (en) * 2020-05-06 2020-08-03 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Use of dalargin for production of drug preparations for preventing pneumonia

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US5371197A (en) * 1991-09-24 1994-12-06 Merck & Co., Inc. Protein-dimeric polysaccharide conjugate vaccine
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
JP2000511769A (en) 1996-04-02 2000-09-12 スミスクライン・ビーチャム・コーポレイション New compound
DE69737125T3 (en) * 1996-10-31 2015-02-26 Human Genome Sciences, Inc. Streptococcus pneumoniae antigens and vaccines
CN1268178A (en) 1997-05-06 2000-09-27 人体基因组科学有限公司 i (Enterococcus faecalis) polynucleotides and polypeptides
CA2294568A1 (en) 1997-06-20 1998-12-30 Human Genome Sciences, Inc. Lyme disease vaccines
US6800744B1 (en) * 1997-07-02 2004-10-05 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US5882885A (en) * 1997-07-17 1999-03-16 Smithkline Beecham Corporation Glycogen phosphorylase
US5994101A (en) * 1997-07-18 1999-11-30 Smithkline Beecham Corporation DNA encoding gidA1 polypeptides
US6617156B1 (en) * 1997-08-15 2003-09-09 Lynn A. Doucette-Stamm Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
EP1144640A3 (en) 1998-07-27 2001-11-28 Microbial Technics Limited Nucleic acids and proteins from streptococcus pneumoniae
EP1185297B1 (en) 1999-06-10 2006-05-10 MedImmune, Inc. Streptococcus pneumoniae proteins and vaccines
US6887480B1 (en) * 1999-06-10 2005-05-03 Medimmune, Inc. Streptococcus pneumoniae proteins and vaccines
HUP0203880A2 (en) * 1999-12-23 2003-03-28 Vmax Limited Streptococcus pyogenes virulence genes and proteins and their use
US6783939B2 (en) * 2000-07-07 2004-08-31 Alphavax, Inc. Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
EP2261241A1 (en) 2001-04-16 2010-12-15 Wyeth Holdings Corporation Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
US20040029129A1 (en) * 2001-10-25 2004-02-12 Liangsu Wang Identification of essential genes in microorganisms
US7314974B2 (en) * 2002-02-21 2008-01-01 Monsanto Technology, Llc Expression of microbial proteins in plants for production of plants with improved properties
EP2275121B1 (en) * 2002-04-02 2013-06-12 Ben Gurion University Of The Negev Research And Development Authority Protein-based streptococcus pneumoniae vaccines
US20090252756A1 (en) * 2002-04-02 2009-10-08 Yaffa Mizrachi-Nebenzahl Protein-based streptococcus pneumoniae vaccines
US20070053924A1 (en) * 2002-08-26 2007-03-08 Herve Tettelin Conserved and specific streptococcal genomes
WO2004020609A2 (en) 2002-08-30 2004-03-11 Tufts University Streptococcus pneumoniae antigens for diagnosis, treatment and prevention of active infection
CA2522238A1 (en) 2003-04-15 2004-10-28 Intercell Ag S. pneumoniae antigens
GB0318688D0 (en) * 2003-08-08 2003-09-10 Chiron Srl Streptococcus pneumoniae knockout mutants
MX2007007033A (en) 2004-12-22 2007-08-03 Novartis Vaccines & Diagnostic Group b streptococcus.
WO2006084466A2 (en) * 2005-02-11 2006-08-17 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides
US20110177960A1 (en) * 2006-03-10 2011-07-21 Ellen Murphy Microarray for monitoring gene expression in multiple strains of Streptococcus pneumoniae
PT2054431E (en) * 2006-06-09 2011-11-03 Novartis Ag Conformers of bacterial adhesins
GB0700136D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Process for manufacturing vaccines
WO2008119358A2 (en) 2007-03-30 2008-10-09 Ace Biosciences A/S Surface-located streptococcus pneumoniae polypeptides for use in vaccine compositions
WO2009011971A2 (en) 2007-05-18 2009-01-22 The Govt. Of The U.S.A. As Represented By The Secretary Of The Dept. Of Health And Human Services, Centers For Disease Control And Prevention Primers and probes for the detection of streptococcus pneumoniae
CN101848929A (en) 2007-05-25 2010-09-29 诺华有限公司 Streptococcus pneumoniae pilus antigens
US20100247547A1 (en) * 2007-05-29 2010-09-30 Chen Dong Modulation of the th-17 cell mediated immune responses
GB0714963D0 (en) 2007-08-01 2007-09-12 Novartis Ag Compositions comprising antigens
US20100278819A1 (en) * 2007-09-14 2010-11-04 Katholieke Universiteit Leuven Streptococcus pneumoniae vaccines
US7833776B2 (en) * 2007-12-12 2010-11-16 National Health Research Institutes Lipidating sequences and use thereof for producing lipidated proteins in E. coli
US8466259B2 (en) * 2007-12-07 2013-06-18 National Health Research Institutes Adjuvants
WO2009114207A2 (en) * 2008-03-14 2009-09-17 Sanofi Pasteur Biologics Co. Replication-defective flavivirus vaccines and vaccine vectors
AU2009266924B2 (en) 2008-07-01 2015-12-10 Genocea Biosciences, Inc. Antigen screening system
KR20110091560A (en) 2008-12-03 2011-08-11 프로테아 벡신 테크놀로지스 엘티디. Glutamyl trna synthetase (gts) fragments
US8287880B2 (en) * 2009-06-02 2012-10-16 National Health Research Institutes Lipidated vaccine against dengue virus infection
TWI409275B (en) * 2009-06-22 2013-09-21 Nat Health Research Institutes Lipidated tumor-associated antigens and immunotherapeutic compositions
US20120100172A1 (en) * 2009-06-25 2012-04-26 Michael Tal Immunogenic streptococcus pneumoniae peptides and peptide-multimers
WO2011008548A1 (en) 2009-06-29 2011-01-20 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae
WO2011064781A1 (en) 2009-11-30 2011-06-03 Ben-Gurion University Of The Negev Research And Development Authority S. pneumoniae adhesins
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
JP5065434B2 (en) * 2010-04-06 2012-10-31 株式会社日立製作所 Management method and management apparatus
WO2011128892A2 (en) 2010-04-12 2011-10-20 Protea Vaccine Technologies Ltd. Modified forms of pneumococcal surface immunogenic protein b (psipb)
US20110283062A1 (en) * 2010-05-14 2011-11-17 Hitachi, Ltd. Storage apparatus and data retaining method for storage apparatus
WO2012100234A1 (en) * 2011-01-20 2012-07-26 Genocea Biosciences, Inc. Vaccines and compositions against streptococcus pneumoniae

Also Published As

Publication number Publication date
US20190298795A1 (en) 2019-10-03
AU2010273708A8 (en) 2012-06-14
EP2448592A1 (en) 2012-05-09
EP2448592B1 (en) 2020-06-17
WO2011008548A1 (en) 2011-01-20
RU2011153032A (en) 2013-08-10
MX2012000158A (en) 2012-06-08
RU2580299C2 (en) 2016-04-10
WO2011008548A8 (en) 2012-03-08
EP2448592A4 (en) 2013-04-24
AU2010273708B2 (en) 2015-10-01
NZ597858A (en) 2014-01-31
JP2012532134A (en) 2012-12-13
US20110020386A1 (en) 2011-01-27
KR101748453B1 (en) 2017-06-16
CN107126557A (en) 2017-09-05
IN2012DN00791A (en) 2015-06-26
US10105412B2 (en) 2018-10-23
JP5931724B2 (en) 2016-06-08
CN102548572A (en) 2012-07-04
AU2010273708A1 (en) 2012-02-23
CA2803061A1 (en) 2011-01-20
BRPI1011919A2 (en) 2017-09-26
KR20120093141A (en) 2012-08-22
SG177402A1 (en) 2012-02-28
IL217166A0 (en) 2012-02-29
US11207375B2 (en) 2021-12-28

Similar Documents

Publication Publication Date Title
SG10201403702SA (en) Vaccines and compositions against streptococcus pneumoniae
HRP20181493T1 (en) Epsilon-polylysine conjugates and use thereof
IL215389A0 (en) Pneumococcal vaccine and uses thereof
EP2515946A4 (en) Nanoconjugates and nanoconjugate formulations
SG10201600435UA (en) Vaccines And Compositions Against Streptococcus Pneumoniae
PL2575493T3 (en) Confectionery composition and article
EP2416801A4 (en) Immunogenic composition and uses thereof
EP2402429A4 (en) Equol-producing bacterium and use thereof
IL209027A0 (en) Vaccine compositions and uses thereof
EP2515940A4 (en) Immunogenic compositions and related methods
HK1213594A1 (en) Immunogenic compositions and uses thereof
ZA201308537B (en) Vaccine against streptococcus pneumoniae
ZA201304517B (en) Composition for immunization against streptococcus pneumoniae
HUE031862T2 (en) Thermo-insulating expanded articles and compositions for the preparation thereof
GB0902429D0 (en) Compositions and their use
GB0901494D0 (en) Compositions and Methods
IL218869A (en) Oligomer-calcimimetic conjugates and compositions comprising the same
ZA201200260B (en) Polyphenylsulphone-polytetrafluroethylene compositions and use thereof
EP2408808A4 (en) Terminally-functionalized conjugates and uses thereof
GB0909792D0 (en) Composition and uses thereof
EP2411029A4 (en) Neuroprotective compositions and methods
GB0909720D0 (en) Compositions and methods
GB0903913D0 (en) Compositions and methods
GB0908498D0 (en) Compositions and methods
GB0907616D0 (en) Methods and compositions